Involvement of apoptotic signals in cyclosporin A-induced proliferation of human gingival fibroblast

사람 치은 섬유모세포에서 Cyclosporin-A 유도 세포증식에 대한 항세포고사 기전

  • Jeong, Tea-Sul (Department of Periodontology, Chonnam National University) ;
  • Chung, Hyun-Ju (Department of Periodontology, Chonnam National University, Dental Science Research Institute, Chonnam National University) ;
  • Kim, Won-Jae (Department of Oral Physiology, Chonnam National University, Dental Science Research Institute, Chonnam National University)
  • 정태술 (전남대학교 치과대학 치주과학교실) ;
  • 정현주 (전남대학교 치과대학 치주과학교실, 전남대학교 치의학연구소) ;
  • 김원재 (전남대학교 구강생리학교실, 전남대학교 치의학연구소)
  • Published : 2005.09.30

Abstract

Cyclosproin A(CsA)는 세포 이식거부방지를 위한 면역 억제제 및 자가 면역질환 치료제로 널리 사용되어 왔다. CsA는 매양된 사람 치은섬유아세포를 증식시킴이 알려져 있지만 CsA에 의한 세포증식기전에 대한 세포사멸기전 및 Bcl-2의 역할은 연구되어 있지 않다. 이번 연구는 사람 섬유아세포에서 CsA에 의한 세포증삭기전에 세포고사기전 및 Bcl-2 family가 관여하는지 밝히는 데에 목적이 있다. 세포 생장력은 MTT 방법으로 측정하였다. Bcl-2 family와 Fas 발현 정도는 RT-PCR 방법이나 western blot으로 확인하였다. Caspase-3 및 -9의 활성은 ELISER reader로, reactive oxygen species(ROS)는 fluorescence spectrometer에 의해 측정되었다. 미토콘드리아에서 세포질로 분비된 cytochrome c는 Western blot으로 조사하였다. CsA는 $0.1{\sim}10\;{\mu}M$에서 사람 섬유아세포의 생존률을 시간과 농도 의존적으로 증가시켰으며, 50 ${\mu}M$ CsA에서는 오히려 세포가 죽였다. 또한, CsA 처리로 미토콘드리아에서 세포질로 유리되는 cytochrome c 양과 VDAC 1 및 3 발현량이 감소되었고, caspase-9과 caspase-3의 활성도도 감소되었다. 한편, CsA 처리한 섬유아세포에서 death receptor 구성요소인 Fas 발현이 감소되었다. Bcl-2 family에 대한 RT-PCR, western blot 분석결과, 세포고사를 억제하는 Bel-2 발현은 증가되었으나 세포고사를 자극하는 Bax와 Bid의 발현은 감소되었다. 이러한 결과들은 사람 섬유아세포에서 CsA유도 세포증식에 Bcl-2 family와 ROS가 매개하는 미토콘드리아 의존 및 death receptor 의존 세포고사기전이 관여함을 시사하였다.

Keywords

References

  1. Faulds D, Goa KL and Benfield P, Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders, Drugs 1993:45(6): 953-1040 https://doi.org/10.2165/00003495-199345060-00007
  2. Wysocki GP, Gretzinger HA, Laupacis A, Ulan RA and Stiller CR. Fibrous hyperplasia of the gingiva, A side effect of cyclosporin A therapy. Oral Surg, Oral Med, Oral Pathol 1983:55:274-278 https://doi.org/10.1016/0030-4220(83)90327-4
  3. Paul LC, Overview of side effects of immunosuppressive therapy, Transplant Proc 2001:33:2089-2091 https://doi.org/10.1016/S0041-1345(01)01959-5
  4. Daley TF, Wysocki GP and Day C, Clinical and pharmacological correlations in cyclosporine induced gingival hyperplasia, Oral Surg, Oral Med, Oral Pathol 1986:62:417-421 https://doi.org/10.1016/0030-4220(86)90291-4
  5. Chabria D, Weintraub RG and Kilpatrick NM, Mechanisms and management of gingival overgrowth in paediatric transplant recipients: a review, Int J Paediatr Dent 2003:13(4):220-229 https://doi.org/10.1046/j.1365-263X.2003.00465.x
  6. Jacobs D and Hassel TM. The effect of cyclosporin metabolite OL-17 on gingival fibroblast sub populations, J Dent Res 1990: 69: 221
  7. Hassel T, Buchanan J, Cuchens M and Doudhlas J. Fluoresence activated vital cell sorting of human fibroblasts subpopulations that bind Cyclosporine A. J Dent Res 1988:67:273
  8. Tipton DA, Stricklin GP, and Dabbous MK. Fibroblast heterogeneity of collagenolytic response to cyclosporine. J Cell Biochem 1991:46: 152-165 https://doi.org/10.1002/jcb.240460209
  9. Coley C. Jarvis K and Hassell T. Effect of cyclosporine-A on human gingival fibroblasts in vitro. J Dent Res 1986; 65:353
  10. Schincaglia GP. Forniti F. Cavallini R. Piva R. Calura G and del Senno L. Cyclosporin-A increases type I procollagen production and mRNA level in human gingival fibroblasts in vitro. J Oral Pathol Med 1992;21(4):181-185 https://doi.org/10.1111/j.1600-0714.1992.tb00098.x
  11. Williamson MS. Miller EK. Plemens J. Rees T and Iacopino AM. Cyclosporine-A upregulates interleukin-f gene expression in human gingiva: possible mechanism for gingival overgrowth. J Periodontol 1994;65(10) :895-903 https://doi.org/10.1902/jop.1994.65.10.895
  12. Cotrim P. Martelli-Junior H. Graner E. Sauk JJ and Coletta RD. Cyclosporin A induces proliferation in human gingival fibroblasts via induction of transforming growth factor-beta 1. J Periodontol 2003; 74(11): 1625-1633 https://doi.org/10.1902/jop.2003.74.11.1625
  13. Hyland PL. McKeown ST. Mackenzie IC and Irwin CR. Regulation of keratinocyte growth factor and scatter factor in cyclosporin-induced gingival overgrowth. J Oral Pathol Med 2004;33(7) :391-397 https://doi.org/10.1111/j.1600-0714.2004.00223.x
  14. Iacopino AM. Doxey D and Cutler CW. Phenytoin and cyclosporine A specifically regulate macrophage and expression of platelet derived growth factor and interleukinl in vitro and in vivo: possible mechanism of drug induced overgrowth. J Periodontol 1997; 68: 73-83 https://doi.org/10.1902/jop.1997.68.1.73
  15. Chen DF, Schneider GE. Martinou JC and Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 1997:385(6615): 391-393 https://doi.org/10.1038/385391a0
  16. Roth JA, Feng L. Walowitz J and Browne RW. Manganese -induced rat pheochromocytoma cell death is independent of caspase activation. J Neurosci Res 2000;61:162-171 https://doi.org/10.1002/1097-4547(20000715)61:2<162::AID-JNR7>3.0.CO;2-G
  17. Crompton M. Mitochondrial intermembrane junctional complexes and their role in cell death. J Physiol 2000; 529 : 11-21 https://doi.org/10.1111/j.1469-7793.2000.00011.x
  18. Adams JM and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-1326 https://doi.org/10.1126/science.281.5381.1322
  19. Tsujimoto Y and Shimizu S. Bcl-2: Life-or-death switch. FEBS Lett 2000;466: 6-10 https://doi.org/10.1016/S0014-5793(99)01761-5
  20. Beer R Frenz G. Schopf M. Reindl M. Zelger B. Schmutzhard E. Poewe W and Kampfl A. Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat. J Cereb Blood Flow Metab. 2000:20: 669-677
  21. Phipps RP. Borrello MA and Blieden TM. Fibroblast heterogeneity in the periodontium and other tissues. J Periodontal Res 1997:32(1-2):159-165 https://doi.org/10.1111/j.1600-0765.1997.tb01398.x
  22. Mascarell L. Auger R, Alcover A. Ojcius DM. Jungas T. Cadet-Daniel V. Kanellopoulos JM and Truffa-Bachi P. Characterization of a gene encoding two isoforms of a mitochondrial protein upregulated by cyclosporin A in activated T cells. J Biol Chem 2004;279(11): 10556 -10563 https://doi.org/10.1074/jbc.M313770200
  23. Takahashi T and Kamimura A. Cyclesporin a promotes hair epithelial cell proliferation and modulates protein kinase C expression and translocation in hair epithelial cells. J Invest Dermatol 2001:117(3):605-611 https://doi.org/10.1046/j.0022-202x.2001.01452.x
  24. Limana F, Urbanek K, Chimenti S, Quaini F, Leri A Kajstura J, NadalGinard B, Izumo Sand Anversa P. bcl-2 overexpression promotes myocyte proliferation. Proc Natl Acad Sci USA 2002: 99(9):6257-6262 https://doi.org/10.1073/pnas.092672899
  25. Nor JE, Christensen J, Liu J, Peters M, Mooney DJ, Strieter RM. Polverini PJ. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 2001:61(5) :2183-2188
  26. Bonnefoy-Berard N, Aouacheria A, Verschelde C, Quemeneur L, Marcais A and Marvel J. Control of proliferation by Bcl-2 family members. Biochem Biophys Acta 2004:1644(2-3):159-168 https://doi.org/10.1016/j.bbamcr.2003.10.014
  27. Furukawa Y, Iwase S, Kikuchi J, Terui Y, Nakamura M. Yamada H, Kano Y and Matsuda M. Phosphorylation of Bcl-2 protein by CDC2 kinase during G2/M phases and its role in cell cycle regulation J Biol Chem 2000: 275(28): 21661-21667 https://doi.org/10.1074/jbc.M906893199
  28. Scatena CD, Stewart ZA, Mays D, Tang LJ, Keefer CJ, Leach SD and Pietenpol JA. Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest. J Biol Chem 1998:273:30777-30784 https://doi.org/10.1074/jbc.273.46.30777
  29. Deng X, Gao F and May WS. Bcl2 retards G1/S cell cycle transition by regulating intracellular ROS. Blood 2003 : 3179-3185
  30. Thornberry NA, Rano TA. Peterson EP, Rasper DM. Timkey T. Garcia-Calve M, Houtzager VM. Nordstrom PA. Roy S. Vaillancourt JP. Chapman KT and Nicholson DW. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 1997:272:17907-17911 https://doi.org/10.1074/jbc.272.29.17907
  31. Li P. Nijhawan D. Budihardjo I. Srinivasula SM. Ahmad M. Alnemri ES and Wand X. Cytochrome c and dATP-dependent formation of Aparf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997: 91 : 479-489 https://doi.org/10.1016/S0092-8674(00)80434-1
  32. Araya R. Uehara T and Nomura Y. Hypoxia induces apoptosis in human neuroblastoma SK-N-MC cells by caspase activation accompanying cytochrome c release from mitochondria. FEBS Lett 1998:439:168-172 https://doi.org/10.1016/S0014-5793(98)01363-5
  33. Wang K. Yin XM. Chao DT. Milliman CL and Korsmeyer SJ. BID: a novel BH3 domain-only death agonist. Genes Dev 1996:10:2859-2869 https://doi.org/10.1101/gad.10.22.2859
  34. Gross A, Yin XM. Wang K. Wei MC. Jockel J. Milliman C. Erdiumcnt-Bromage H, Tempst P and Korsmeyer SJ Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 1999:274: 1156-1163 https://doi.org/10.1074/jbc.274.2.1156
  35. Martinou JC and Green DR. Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2001: 2: 63-67 https://doi.org/10.1038/35048069
  36. Zamzami N and Kroemer G. The mitochondrion in apoptosis how Pandora's box opens. Nat Rev Mol Cell Biol 2001:2:67-71 https://doi.org/10.1038/35048073
  37. Zamzami N, Marchetti P, Castedo M. Hirsch T, Susin SA, Masse Band Kroemer G. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett 1996:384:53-57 https://doi.org/10.1016/0014-5793(96)00280-3
  38. Petronilli V, Nicolli A Costantini P, Colonna R. and Bernardi P. Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. Biochim Biophys Acta 1994:1187:255-259 https://doi.org/10.1016/0005-2728(94)90122-8